Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

1.2K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.2K
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

16
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
16
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

1.6K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.6K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

541
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
541
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

21
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
21
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

725
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
725

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic Pancreatitis.

Digestive diseases and sciences·2026
Same author

Leveraging Machine Learning to Predict Delayed Graft Function Occurrence and Length in Kidney Transplant Recipients.

Clinical transplantation·2026
Same author

Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Negative trial, positive lessons: refining endpoints and eligibility in RAP/CP prevention studies.

Gut·2026
Same author

Pancrelipase Treatment of Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis: Rationale and Methodology of a Real-World, Prospective, Observational Study.

Pancreas·2025
Same author

Empowering patients through pharmacovigilance, transparency, and health literacy: a narrative review.

Current medical research and opinion·2025

Related Experiment Video

Updated: Apr 19, 2026

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

5.3K

Pharmacologic therapy for acute pancreatitis.

Swetha Kambhampati1, Walter Park1, Aida Habtezion1

  • 1Swetha Kambhampati, Walter Park, Aida Habtezion, Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States.

World Journal of Gastroenterology
|December 11, 2014
PubMed
Summary

New drug therapies show promise for acute pancreatitis, moving beyond traditional treatments. While preclinical studies are encouraging, clinical trials have yielded mixed results, highlighting the need for further research into targeted pharmacologic approaches.

Keywords:
Acute pancreatitisAnti-inflammatoryAnti-oxidantsAntisecretoryMortalityOrgan failureProtease inhibitorsSystemic inflammatory response syndrome

More Related Videos

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

1.7K
Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

4.7K

Related Experiment Videos

Last Updated: Apr 19, 2026

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

5.3K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

1.7K
Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

4.7K

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Conservative management (fluids, bowel rest, antibiotics) is standard for acute pancreatitis.
  • Emerging pharmacologic therapies targeting pancreatitis pathogenesis show promise.

Purpose of the Study:

  • To review preclinical studies of novel pharmacologic therapies for acute pancreatitis.
  • To discuss potential targeted approaches for future clinical investigation.

Main Methods:

  • Extensive review of preclinical studies on various agents (anti-secretory, protease inhibitors, anti-inflammatory, anti-oxidants).
  • Analysis of translational potential from animal models to human studies.

Main Results:

  • Preclinical studies demonstrate therapeutic benefits and improved survival in experimental models.
  • Clinical studies translating these therapies have shown failure or mixed results in humans.

Conclusions:

  • Despite clinical trial setbacks, a significant unmet need exists for effective acute pancreatitis treatments.
  • Further research into novel pharmacologic agents, informed by pathophysiology and past studies, is warranted.